Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2044 - A Pilot Study for CT-Based Online Adaptive Radiotherapy in Patients with Newly Diagnosed High-Grade Glioma
Speaker: Daniell, Kayla, MD - Columbia University Irving Medical Center, New York, NY
3:00 PM - 4:00 PM ET

2045 - Impact of Doses to Hippocampal Subregions on Neurocognitive Outcomes in Patients with Primary Brain Tumors Treated with Intensity Modulated Proton Therapy
Speaker: Sharma, Prashasti, MD - Advanced Centre for Treatment, Research and Education in Cancer, Tata memorial Centre, Mumbai
3:00 PM - 4:00 PM ET

2046 - Volumetric Changes in High-Grade IDH Mutant Diffuse Gliomas Treated with Reduced Margin Adaptive Intensity Modulated Proton Therapy
Speaker: Malhotra, Rahat, MD - Tata Memorial Hospital, Mumbai, Maharashtr
3:00 PM - 4:00 PM ET

2047 - Treated and Replanned Hippocampal Doses in Patients Receiving Photon vs. Proton RT for Favorable Grade 2-3 IDHmt Gliomas
Speaker: Davis, Alyssa, BS - University of Cincinnati, Cincinnati, OH
3:00 PM - 4:00 PM ET

2048 - Incidence of Radiation Necrosis and Local Failure in Small Brain Metastases Treated with Single-Fraction vs. Multi-Fraction Stereotactic Radiosurgery
Speaker: del Balzo, Luke, MD - Emory University Hospital, Atlanta, GA
3:00 PM - 4:00 PM ET

2049 - Cranial Radiotherapy and Local Fraction Dose for Treatment-Naive EGFR-Mutant NSCLC with Brain Metastases on First-Line 3<sup>rd</sup>-Generation TKIs, Stratified by Lung-molGPA: A Multi-Center Retrospective Analysis
Speaker: Deng, Guangchuan - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences,, Ji Nan
11:05 AM - 11:15 AM ET

205 - 30Gy vs 40Gy Consolidative Radiotherapy for Limited-Stage Diffuse Large B cell Lymphoma Achieving Complete Remission after Chemotherapy: A Randomized, Open-Label, Non-Inferiority, Multicenter Phase 3 Clinical Trial
Speaker: Liu, Xin, MD - State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PU, Beijing
3:00 PM - 4:00 PM ET

2050 - External Validation of a Spine SBRT Pain Flare Risk Stratification Model: A Foundation for aFuture Alliance Trial
Speaker: Dibs, Khaled, MD - Ohio State University Wexner Medical Center, Columbus, OH
3:00 PM - 4:00 PM ET

2051 - Preoperative Circulating Cell-Free DNA as a Prognostic Biomarker in Surgically Treated Spinal Metastatic Disease
Speaker: Dibs, Khaled, MD - Ohio State University Wexner Medical Center, Columbus, OH
3:00 PM - 4:00 PM ET

2052 - Dosimetric Tolerances of the Brainstem and Anterior Optic Pathway to Re-Irradiation In Recurrent Gliomas
Speaker: Djavadian, Reza, MD, PhD - University of Alabama at Birmingham, Birmingham, AL
3:00 PM - 4:00 PM ET

2053 - Treatment Pathway, Not Histology, Determines Survival in a 10-Year Radical-Intent Oesophageal Cancer Cohort
Speaker: Dobeson, Caroline - The Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne
3:00 PM - 4:00 PM ET

2054 - Stereotactic Body Radiotherapy after Whipple Resection: Feasibility, Toxicity and Local Control
Speaker: Ebrahimi, Sasha, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA